Literature DB >> 7520094

Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.

J S Smith1, K Gritsman, M J Roth.   

Abstract

Previous studies showed that an isolated human immunodeficiency virus type 1 (HIV-1) RNase H domain expressed as a fusion protein is highly active in Mn2+, but activity was dependent on a hexahistidine tag located at either the carboxyl or amino terminus of the fusion protein (J. Smith and M. Roth, J. Virol. 67:4037-4049, 1993). It was postulated that a histidine tag can somehow provide a function normally associated with the DNA polymerase domain of HIV-1 reverse transcriptase. To determine the contributions of the DNA polymerase subdomains of HIV-1 reverse transcriptase to its RNase H activity, we have characterized the activity of isolated RNase H domains which include either portions of the connection, the entire connection, or both the thumb and connection as N-terminal extensions. Including increasing lengths of these domains at the N terminus of the RNase H resulted in a progressive increase in Mn(2+)-dependent RNase H activity that was independent of a histidine tag. Activity of the isolated RNase H domains was also stimulated by the addition of independently purified polymerase subdomains. Further, this stimulation was shown to be a result of direct physical interactions between the thumb, connection, and RNase H domains. The connection and thumb subdomains were shown to contribute to substrate binding. The fingers and palm subdomains were found to be essential for Mg(2+)-dependent RNase H activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520094      PMCID: PMC236975     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

5.  Gene product of Moloney murine leukemia virus required for proviral integration is a DNA-binding protein.

Authors:  M J Roth; N Tanese; S P Goff
Journal:  J Mol Biol       Date:  1988-09-05       Impact factor: 5.469

6.  Three-dimensional structure of ribonuclease H from E. coli.

Authors:  K Katayanagi; M Miyagawa; M Matsushima; M Ishikawa; S Kanaya; M Ikehara; T Matsuzaki; K Morikawa
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

7.  Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.

Authors:  A Hizi; S H Hughes; M Shaharabany
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

8.  Human immunodeficiency virus reverse transcriptase. Effect of primer length on template-primer binding.

Authors:  J E Reardon; E S Furfine; N Cheng
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

9.  Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein.

Authors:  W Yang; W A Hendrickson; R J Crouch; Y Satow
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

10.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  23 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication.

Authors:  Jennifer L Brincat; Julie K Pfeiffer; Alice Telesnitsky
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.

Authors:  Richard V Farias; Deborah A Vargas; Andres E Castillo; Beatriz Valenzuela; Marie L Coté; Monica J Roth; Oscar Leon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

4.  Crystal structure of the moloney murine leukemia virus RNase H domain.

Authors:  David Lim; G Glenn Gregorio; Craig Bingman; Erik Martinez-Hackert; Wayne A Hendrickson; Stephen P Goff
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  Hsp70's RNA-binding and mRNA-stabilizing activities are independent of its protein chaperone functions.

Authors:  Aparna Kishor; Elizabeth J F White; Aerielle E Matsangos; Zisui Yan; Bishal Tandukar; Gerald M Wilson
Journal:  J Biol Chem       Date:  2017-07-05       Impact factor: 5.157

7.  Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.

Authors:  Angela Corona; Anna Schneider; Kristian Schweimer; Paul Rösch; Birgitta M Wöhrl; Enzo Tramontano
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

8.  Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins.

Authors:  Eric A Hehl; Pheroze Joshi; Ganjam V Kalpana; Vinayaka R Prasad
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.

Authors:  David Lim; Marianna Orlova; Stephen P Goff
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.